TrialInternational journal of clinical oncology2022

How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?

Fumihiko Urabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.